Search Results

The flipbook can be used by healthcare personnel to provide patient education for persons at risk for TB infection. The flipbook can also be used to provide patient education for persons newly diagnosed with LTBI. This product was developed in collaboration with the Chuuk State TB and Hansen’s...

This guide provides a summary of safety and efficacy data for drugs currently in use to treat TB. The guide also suggests advocacy points for activists, clinicians, and others working in TB.

This guide is designed to explain the safety and efficacy of bedaquiline. It also describes what you as an activist can do to help ensure access, fair pricing and further research. The guide provides messages that regulatory authorities need to hear to prepare for bedaquiline and other new TB drugs.

Dr. Kenneth Castro, Director of CDC's Division of Tuberculosis Elimination, discusses the impact of TB on those who are HIV infected and the importance of detecting and curing TB.

This fact sheet introduces the TB blood test, also called an Interferon Gamma Release Assay or IGRA.

The Communications, Education, and Behavioral Studies Branch (CEBSB) in the Division of Tuberculosis Elimination (DTBE) at CDC developed a video podcast on the 12-dose treatment regimen for latent tuberculosis infection. The video podcast features Dr. Kenneth Castro and is available in English and...

This pilot curriculum for accompagnateurs comprises 15 units, with a focus on treatment and support for patients with HIV/AIDS and tuberculosis. Accompagnateurs are community health workers trained and employed to provide medical and psychosocial support for their neighbors. This curriculum contains...

This information sheet discusses targeted tuberculin testing focusing on the groups at highest risk for latent TB infection (LTBI). It advises that testing should be given to those at highest risk for developing TB, and once TB disease has been ruled out, then it should be offered to those who would...

This information sheet discusses treatment for individuals with latent tuberculosis infection (LTBI), with the purpose of this treatment being the reduction of the risk that the infection will progress to TB disease. It explains how the health care provider determines whether the individual with a...

This poster promotes World TB Day March 24, 2014. World TB Day provides an opportunity to raise awareness about TB and to support the worldwide fight against TB.